decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
seed logo
FAQs NIH Staff Contact & Help

Metaclipse Therapeutics

Metaclipse Therapeutics Corporation aims to be a leader in developing next-generation immunotherapies to treat cancer & vaccines to prevent infectious diseases using our proprietary biological adjuvants. Its personalized immunotherapy platform, Membrex™, has demonstrated promising preclinical data across multiple solid tumors with Phase 1 clinical trials for triple-negative breast cancer (TNBC) and head and neck cancer (HNSCC) to begin in early 2024. The company is committed to continuous innovation using biological adjuvants for therapeutic and preventative vaccines.
Company Ownership: Socially Disadvantaged
Contact Name:
Michael Coleman
Contact Email:
[email protected]
Website: http://metaclipse.com/
City, State – Congressional District: Atlanta,
GA
–
5
Funding: Allergy and Infectious Diseases (NIAID), Cancer (NCI)
NIH Projects: NIH RePorter for Metaclipse Therapeutics
Sponsored Event(s): Angel Capital Association | 2024 , Life Sciences Summit | 2020
National Institutes of Health
Bethesda, MD 20892

Stay in the Loop

Subscribe to our mailing list for updates on deadlines and important information.

Site Map

Fraud, Waste and Abuse

HHS Vulnerability Disclosure | Technical Issues: E-mail OER Webmaster